Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 36Prostatic Neoplasms 27Carcinoma, Non-Small-Cell Lung 14Lymphoma 13Rectal Neoplasms 11Lung Neoplasms 11Head and Neck Neoplasms 11Recurrence 10Neoplasms 10Neoplasm Metastasis 9Carcinoma, Hepatocellular 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Esophageal Squamous Cell Carcinoma 8Esophageal Neoplasms 8Uterine Cervical Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 7Leukemia 7Central Nervous System Neoplasms 7Brain Neoplasms 7Multiple Myeloma 6Hyperthermia 6Carcinoma, Intraductal, Noninfiltrating 6Lymphoma, Follicular 5Hodgkin Disease 5Glioblastoma 5Dendritic Cell Sarcoma, Interdigitating 5Congenital Abnormalities 5Colorectal Neoplasms 5

Interventions

etoposide phosphate 1Ursodeoxycholic Acid 1Thiotepa 1Radiotherapy, Image-Guided 1Radiotherapy 1Radiation 1Paclitaxel 1Neoadjuvant Therapy 1Mesna 1Melphalan 1Leukapheresis 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Gelclair 1Etoposide 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Rhabdoid Tumor × Radiotherapy × Clear all
NCT01233479 2019-04-01

Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

Pediatric Brain Tumor Consortium

Phase NA Withdrawn
CNS

Central Nervous System Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡